Goldman Sachs’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,642
| Closed | -$236K | – | 4979 |
|
|
2023
Q4 | $236K | Sell |
5,642
-12,072
| -68% | -$504K | ﹤0.01% | 4269 |
|
|
2023
Q3 | $668K | Buy |
17,714
+8,044
| +83% | +$303K | ﹤0.01% | 3747 |
|
|
2023
Q2 | $367K | Buy |
+9,670
| New | +$367K | ﹤0.01% | 4131 |
|
|
2022
Q4 | – | Sell |
-7,854
| Closed | -$235K | – | 5408 |
|
|
2022
Q3 | $235K | Sell |
7,854
-9,743
| -55% | -$292K | ﹤0.01% | 4652 |
|
|
2022
Q2 | $636K | Buy |
17,597
+8,635
| +96% | +$312K | ﹤0.01% | 4226 |
|
|
2022
Q1 | $388K | Buy |
8,962
+788
| +10% | +$34.1K | ﹤0.01% | 4737 |
|
|
2021
Q4 | $410K | Sell |
8,174
-702
| -8% | -$35.2K | ﹤0.01% | 4627 |
|
|
2021
Q3 | $565K | Sell |
8,876
-6,411
| -42% | -$408K | ﹤0.01% | 4322 |
|
|
2021
Q2 | $1.1M | Sell |
15,287
-2,294
| -13% | -$165K | ﹤0.01% | 3953 |
|
|
2021
Q1 | $1.3M | Buy |
17,581
+3,417
| +24% | +$252K | ﹤0.01% | 3730 |
|
|
2020
Q4 | $1.04M | Sell |
14,164
-5,251
| -27% | -$386K | ﹤0.01% | 3434 |
|
|
2020
Q3 | $1.07M | Buy |
19,415
+3,668
| +23% | +$201K | ﹤0.01% | 3272 |
|
|
2020
Q2 | $1.05M | Sell |
15,747
-11,199
| -42% | -$745K | ﹤0.01% | 3192 |
|
|
2020
Q1 | $1.65M | Buy |
26,946
+14,313
| +113% | +$876K | ﹤0.01% | 2861 |
|
|
2019
Q4 | $1.11M | Buy |
12,633
+2,234
| +21% | +$196K | ﹤0.01% | 3272 |
|
|
2019
Q3 | $785K | Sell |
10,399
-2,881
| -22% | -$217K | ﹤0.01% | 3376 |
|
|
2019
Q2 | $1.13M | Sell |
13,280
-5,627
| -30% | -$480K | ﹤0.01% | 3114 |
|
|
2019
Q1 | $2.04M | Sell |
18,907
-8,627
| -31% | -$933K | ﹤0.01% | 2933 |
|
|
2018
Q4 | $2.33M | Buy |
27,534
+5,335
| +24% | +$451K | ﹤0.01% | 2734 |
|
|
2018
Q3 | $2.18M | Sell |
22,199
-5,649
| -20% | -$555K | ﹤0.01% | 2836 |
|
|
2018
Q2 | $3.22M | Sell |
27,848
-5,256
| -16% | -$608K | ﹤0.01% | 2629 |
|
|
2018
Q1 | $3.27M | Sell |
33,104
-23,671
| -42% | -$2.34M | ﹤0.01% | 2593 |
|
|
2017
Q4 | $5.95M | Sell |
56,775
-67,713
| -54% | -$7.09M | ﹤0.01% | 2196 |
|
|
2017
Q3 | $14M | Buy |
124,488
+19,423
| +18% | +$2.19M | ﹤0.01% | 1780 |
|
|
2017
Q2 | $11.8M | Sell |
105,065
-5,635
| -5% | -$631K | ﹤0.01% | 1841 |
|
|
2017
Q1 | $12.9M | Sell |
110,700
-2,818
| -2% | -$329K | ﹤0.01% | 1728 |
|
|
2016
Q4 | $12M | Sell |
113,518
-293,259
| -72% | -$30.9M | ﹤0.01% | 1726 |
|
|
2016
Q3 | $45M | Sell |
406,777
-60,183
| -13% | -$6.65M | 0.01% | 1036 |
|
|
2016
Q2 | $68M | Buy |
466,960
+286,329
| +159% | +$41.7M | 0.02% | 742 |
|
|
2016
Q1 | $25.9M | Sell |
180,631
-27,192
| -13% | -$3.9M | 0.01% | 1240 |
|
|
2015
Q4 | $32.1M | Buy |
207,823
+148,195
| +249% | +$22.9M | 0.01% | 1122 |
|
|
2015
Q3 | $8.52M | Buy |
59,628
+12,122
| +26% | +$1.73M | ﹤0.01% | 1706 |
|
|
2015
Q2 | $6.83M | Sell |
47,506
-12,790
| -21% | -$1.84M | ﹤0.01% | 1888 |
|
|
2015
Q1 | $8.5M | Buy |
60,296
+19,481
| +48% | +$2.75M | ﹤0.01% | 1756 |
|
|
2014
Q4 | $6.05M | Buy |
40,815
+15,969
| +64% | +$2.37M | ﹤0.01% | 1873 |
|
|
2014
Q3 | $3.82M | Buy |
24,846
+12,452
| +100% | +$1.92M | ﹤0.01% | 2144 |
|
|
2014
Q2 | $1.74M | Buy |
12,394
+10,425
| +529% | +$1.46M | ﹤0.01% | 2629 |
|
|
2014
Q1 | $219K | Sell |
1,969
-949
| -33% | -$106K | ﹤0.01% | 3880 |
|
|
2013
Q4 | $289K | Buy |
+2,918
| New | +$289K | ﹤0.01% | 3712 |
|